ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 927,62
0,44%
Dow Jones
44 424,25
-0,32%
DAX
21 394,93
-0,11%
Brent Oil
77,625
0,00%
Bitcoin
104 585,24
-0,25%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. SIGA Technologies Inc (SIGA)

  7. SIGA Technologies Inc (SIGA) Actualités

SIGA

SIGA Technologies (SIGA)

SIGA Technologies Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SIGA
DateHeureSourceTitreSymboleSociété
02/01/202513h30GlobeNewswire Inc.TEPOXX (tecovirimat) Approved in Japan for the Treatment of OrthopoxvirusesNASDAQ:SIGASIGA Technologies Inc
13/12/202422h46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SIGASIGA Technologies Inc
10/12/202422h00GlobeNewswire Inc.Interim Results from STOMP Study of SIGA’s Tecovirimat in Treatment of Mpox AnnouncedNASDAQ:SIGASIGA Technologies Inc
08/11/202423h31Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:SIGASIGA Technologies Inc
07/11/202422h55Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SIGASIGA Technologies Inc
07/11/202422h05GlobeNewswire Inc.SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2024NASDAQ:SIGASIGA Technologies Inc
31/10/202412h30GlobeNewswire Inc.SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial ResultsNASDAQ:SIGASIGA Technologies Inc
29/10/202422h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SIGASIGA Technologies Inc
22/10/202413h30GlobeNewswire Inc.SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal AntibodiesNASDAQ:SIGASIGA Technologies Inc
08/10/202413h30GlobeNewswire Inc.SIGA Announces Agreement to Supply TPOXX® in MoroccoNASDAQ:SIGASIGA Technologies Inc
21/08/202422h00GlobeNewswire Inc.SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX®NASDAQ:SIGASIGA Technologies Inc
15/08/202413h35GlobeNewswire Inc.Topline Results from PALM 007 Study of SIGA’s Tecovirimat in Treatment of Mpox ReleasedNASDAQ:SIGASIGA Technologies Inc
01/08/202422h05GlobeNewswire Inc.SIGA Reports Financial Results for Three and Six Months Ended June 30, 2024NASDAQ:SIGASIGA Technologies Inc
25/07/202413h30GlobeNewswire Inc.SIGA to Host Business Update Call on August 1 Following Release of Second-Quarter 2024 Financial ResultsNASDAQ:SIGASIGA Technologies Inc
19/07/202414h00GlobeNewswire Inc.SIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX®NASDAQ:SIGASIGA Technologies Inc
17/06/202422h05GlobeNewswire Inc.SIGA Announces Agreement to Sell TPOXX® to ASEAN Member StatesNASDAQ:SIGASIGA Technologies Inc
07/05/202422h05GlobeNewswire Inc.SIGA Reports Financial Results for Three Months Ended March 31, 2024NASDAQ:SIGASIGA Technologies Inc
01/05/202423h00GlobeNewswire Inc.SIGA Technologies to Host Business Update Call on May 7 Following Release of First-Quarter 2024 Financial ResultsNASDAQ:SIGASIGA Technologies Inc
01/04/202422h05GlobeNewswire Inc.SIGA Amends International Promotion Agreement with Meridian to Enhance International Growth Opportunities of Oral TPOXX®NASDAQ:SIGASIGA Technologies Inc
25/03/202412h30GlobeNewswire Inc.SIGA Names Larry Miller General CounselNASDAQ:SIGASIGA Technologies Inc
12/03/202421h05GlobeNewswire Inc.SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2023NASDAQ:SIGASIGA Technologies Inc
12/03/202412h30GlobeNewswire Inc.SIGA Declares Special Cash Dividend of $0.60 Per ShareNASDAQ:SIGASIGA Technologies Inc
05/03/202413h30GlobeNewswire Inc.SIGA Technologies to Host Business Update Call on March 12th, 2024 Following Release of Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:SIGASIGA Technologies Inc
01/02/202421h54Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SIGASIGA Technologies Inc
30/01/202423h01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SIGASIGA Technologies Inc
22/01/202413h30GlobeNewswire Inc.SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive OfficerNASDAQ:SIGASIGA Technologies Inc
07/11/202322h05GlobeNewswire Inc.SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2023NASDAQ:SIGASIGA Technologies Inc
26/10/202313h30GlobeNewswire Inc.SIGA Technologies to Host Business Update Call on November 7th, 2023 Following Release of Third Quarter 2023 Financial ResultsNASDAQ:SIGASIGA Technologies Inc
23/10/202314h00GlobeNewswire Inc.SIGA Announces Creation of Joint Procurement Mechanism by European Commission with Anticipated Initial Orders of Approximately $18 Million for Oral TPOXX® (Tecovirimat) by Participating CountriesNASDAQ:SIGASIGA Technologies Inc
06/09/202313h30GlobeNewswire Inc.SIGA Technologies Names Dr. Jay K. Varma as EVP and Chief Medical OfficerNASDAQ:SIGASIGA Technologies Inc
 Showing the most relevant articles for your search:NASDAQ:SIGA

Dernières Valeurs Consultées

EU
BEL20
Bel 20
EU
ORA
Orange
EU
ACA
Credit Agricole
EU
AI
Air Liquide
NYSE
NKE
Nike
EU
RI
Pernod Ricard
EU
EN
Bouygues
EU
DG
Vinci
SPI
SP500
S&P 500
EU
AF
Air FranceKLM
EU
SGO
Cie de SaintGobain
EU
MC
Lvmh Moet Hennessy Louis...
NASDAQ
MSFT
Microsoft
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés